从天然免疫介导的代谢性炎性反应角度探讨糖脂代谢病“浊”的生物学本质(7)
[49]Van Rooyen DM,Gan LT,Yeh MM,et al.Pharmacological cholesterol lowering reverses fibrotic NASH in obese,diabetic mice with metabolic syndrome[J].J Hepatol,2013,59(1):144152.
[50]ZelberSagi S,Azar S,Nemirovski A,et al.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease[J].Obesity(Silver Spring),2017,25(1):94101.
[51]Green CL,Mitchell SE,Derous D,et al.The effects of graded levels of calorie restriction:IX.Global metabolomic screen reveals modulation of carnitines,sphingolipids and bile acids in the liver of C57BL/6 mice[J].Aging Cell,2017,16(3):529540.
[52]Vorkas PA,Shalhoub J,Isaac G,et al.Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis[J].J Proteome Res,2015,14(3):13891399.
[53]Cheng JM,Suoniemi M,Kardys I,et al.Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome:Results of the ATHEROREMOIVUS study[J].Atherosclerosis,2015,243(2):560566.
[54]Park JY,Lee SH,Shin MJ,et al.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction[J].PLoS One,2015,10(8):e0135228.
[55]Vorkas PA,Shalhoub J,Lewis MR,et al.Metabolic phenotypes of carotid atherosclerotic plaques relate to stroke risk:an exploratory study[J].Eur J Vasc Endovasc Surg,2016,52(1):510.
(2018-12-10收稿責任编辑:王明), 百拇医药(吴小琴 颜凯旋 杨勇 荣向路)
[50]ZelberSagi S,Azar S,Nemirovski A,et al.Serum levels of endocannabinoids are independently associated with nonalcoholic fatty liver disease[J].Obesity(Silver Spring),2017,25(1):94101.
[51]Green CL,Mitchell SE,Derous D,et al.The effects of graded levels of calorie restriction:IX.Global metabolomic screen reveals modulation of carnitines,sphingolipids and bile acids in the liver of C57BL/6 mice[J].Aging Cell,2017,16(3):529540.
[52]Vorkas PA,Shalhoub J,Isaac G,et al.Metabolic phenotyping of atherosclerotic plaques reveals latent associations between free cholesterol and ceramide metabolism in atherogenesis[J].J Proteome Res,2015,14(3):13891399.
[53]Cheng JM,Suoniemi M,Kardys I,et al.Plasma concentrations of molecular lipid species in relation to coronary plaque characteristics and cardiovascular outcome:Results of the ATHEROREMOIVUS study[J].Atherosclerosis,2015,243(2):560566.
[54]Park JY,Lee SH,Shin MJ,et al.Alteration in metabolic signature and lipid metabolism in patients with angina pectoris and myocardial infarction[J].PLoS One,2015,10(8):e0135228.
[55]Vorkas PA,Shalhoub J,Lewis MR,et al.Metabolic phenotypes of carotid atherosclerotic plaques relate to stroke risk:an exploratory study[J].Eur J Vasc Endovasc Surg,2016,52(1):510.
(2018-12-10收稿責任编辑:王明), 百拇医药(吴小琴 颜凯旋 杨勇 荣向路)